Fast Company

Investors poured nearly $8 billion into synthetic biology last year. This company is leading the field

One of the keys to combating COVID-19—and its variants—is the ability to study its genome and conduct tests on it at scale. And key to this effort is synthetic DNA. Founded in 2013, Twist Bioscience ...
Science Daily

Designing synthetic receptors for precise cell control

Scientists have developed a groundbreaking new technique for engineering biosensors that respond sensitively to specific biomolecules, enhancing cell migration and targeting in cancer treatment. The ...
Nasdaq

Medidata Synthetic Control Arm® Supported by the US Food and Drug Administration (FDA) for Use in Medicenna Therapeutics, Corp. Phase 3 Registrational Trial in Recurrent ...

NEW YORK--(BUSINESS WIRE)-- Medidata, a Dassault Systèmes Company, today announced that the US Food and Drug Administration (FDA) supported the use of a Medidata Synthetic Control Arm® in a phase 3 ...
National Academies of Sciences%2c Engineering%2c and Medicine

The Science and Applications of Synthetic and Systems Biology: Workshop Summary

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...